Corcept Therapeutics, Inc. (CORT)
83.85
+1.86
(+2.27%)
USD |
NASDAQ |
Dec 24, 10:51
Corcept Therapeutics SG&A Expense (TTM): 401.86M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Johnson & Johnson | 23.38B |
| United Therapeutics Corp. | 627.50M |
| Amgen, Inc. | 6.976B |
| Vertex Pharmaceuticals, Inc. | 1.644B |
| Theravance Biopharma, Inc. | 75.94M |